GI Dynamics Announces Additional Members to Its Scientific Advisory Board
GI Dynamics® Inc. (ASX:GID), a medical device company that has commercialized EndoBarrier® in Europe, the Middle East and South America for patients with type 2 diabetes and obesity announced additional members of the GI Dynamics Scientific Advisory Board (SAB), bringing...
GI Dynamics Announces EndoBarrier Data to be Presented at Digestive Disease Week
Digestive Disease Week® (DDW), taking place May 6 – 9, 2017 in Chicago, Illinois
GI Dynamics®, Inc. (ASX:GID), a medical device company that has commercialized EndoBarrier® in Europe, the Middle East and South America for patients with type...
